IL6 and neoplasm: Its anticancer prowess was observed to disrupt the G1/S phase, inducing apoptotic pathways through caspase-3 activation, and orchestrating the downregulation of pivotal cellular regulators such as STAT3, P21, P27, IL-6, and AhR, thereby impeding tumor progression.